Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re: Mallinckrodt plc, et al
Case Number:
1:21-cv-01303
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 13, 2021
Rhode Island Balks At Mallinckrodt Ch. 11's CEO Release
The state of Rhode Island objected Wednesday to the proposed Chapter 11 plan of drugmaker Mallinckrodt PLC, telling a Delaware bankruptcy court that the plan seeks to provide impermissible releases of the state's claims against the debtor's CEO in Rhode Island court.
-
October 06, 2021
Mallinckrodt Facing $93M Drug Royalty Claim In Ch. 11
Drugmaker Mallinckrodt PLC was hit with more legal woes related to sales of its Acthar Gel infantile spasms drug Wednesday after three individuals filed a suit in Delaware bankruptcy court asserting a $93 million royalties claim.
-
September 29, 2021
Judge Orders Mallinckrodt Trial On Acthar Antitrust Claims
A Delaware bankruptcy judge on Wednesday rejected drugmaker Mallinckrodt PLC's bid to block insurer demands for full post-petition, administrative priority payment of monopoly-inflated costs for a drug used to treat infantile spasms, saying the dispute must be decided by trial.